Cogent Biosciences Inc (COGT)

EBITDA Growth

-31.07%

Quarterly · Period ending:

COGT logo

COGT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-31.07%
COGT Quarterly EBITDA YoY % (-108.68% → -31.07%)
High-resolution chart · PNG

COGT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-31.0708%
-34.0673%
-56.5468%
-12.6364%
-24.517%
-23.6828%
-24.7298%
-27.5276%
-35.021%
-51.2835%
-38.4944%
-73.9243%
-23.0548%
-23.8803%
-55.6955%
-64.6932%
-110.6441%
-139.1066%
-117.1868%
-87.2332%
-132.331%
-118.6623%
-547.8857%
13.1743%
30.2938%
48.5433%
130.9426%
-14.2853%
-12.0255%
-70.2788%
-25.5743%
-49.1412%
-58.5871%
-15.2133%
26.2849%
-108.6805%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.